Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13030-13041
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13030
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13030
Figure 1 miR-210 expression is up-regulated in hepatocellular carcinoma.
Reverse transcription-real time PCR analysis of miR-210 in (A) hepatocellular carcinoma (HCC) tumor (T) and paired non-tumor (NT) samples and (B) primary hepatocytes, HepG2 cells and HuH7 cells. Data shown are expressed as mean ± SE for the HCC paired samples with bP < 0.01, Student’s paired t-test analysis for comparison between tumor and paired non-tumor samples; and mean ± SD for the primary hepatocytes and cell lines with bP < 0.01, Student’s t-test analysis for comparison between primary hepatocytes to either HepG2 or HuH7 cells.
- Citation: Tan W, Lim SG, Tan TM. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1. World J Gastroenterol 2015; 21(46): 13030-13041
- URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13030.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13030